Enanta Pharmaceuticals(ENTA) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2025 WATERTOWN, Mass., May 12, 2025 – Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial results for its fiscal second quarter ended March 31, 2025. "Throughout the fiscal second quarter, Enanta remained squarely focused on executing across our virology a ...